FIGURE
Fig. 3
- ID
- ZDB-FIG-221212-3
- Publication
- Lu et al., 2021 - Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 3
Figure 3. Biochemical and biophysical methods demonstrated the direct binding of DC-TEADin1072. (A) TEAD3 thermal shift assays. Synthetic YAP peptide was used as the positive control with the ratio of 1:5. The experiments were performed in biological triplicates. (B) The shift of Tm values of TEAD3-YBD WT and TEAD3-YBD mutants with DC-TEADin1072. (C) and (D) The alignment of DC-TEADin1072 (green) with myristic acid (salmon) (PDB code: 5OAQ)38 and flufenamic acid (grey) (PDB code: 5DQ8)33. (E) and (F) The predicted binding mode of DC-TEADin1072 with TEAD3-YBD in molecular docking studies. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Acta Pharm Sin B